P

Palatin Technologies

PTN

1.65000
USD
-0.03
(-1.79%)
مغلق
حجم التداول
200
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
20,725,811
أصول ذات صلة
A
ACER
0
(0%)
0.000000 USD
A
ALRN
-0.05000
(-2.24%)
2.18000 USD
A
ASRT
-0.02000
(-1.44%)
1.37000 USD
P
PDSB
-0.34000
(-9.52%)
3.23000 USD
P
PLX
-0.02000
(-1.85%)
1.06000 USD
V
VBIV
-0.00920
(-7.34%)
0.11610 USD
Z
ZOM
-0.00010
(-0.07%)
0.14950 USD
الأخبار المقالات

العنوان: Palatin Technologies

القطاع: Healthcare
الصناعة: Biotechnology
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type offemale sexual dysfunction.